|
2024
|
Invention
|
Functionality-enhanced cell therapy. The present invention relates to an engineered cell, charact... |
|
|
Invention
|
Function-enhanced cell therapy. Provided is an engineered cell that expresses an exogenous immuno... |
|
|
Invention
|
Composition and method for allogeneic transplantation. Provided are a composition and method for ... |
|
2023
|
Invention
|
Immune rejection-resistant engineered cell. The present invention relates to an immunosuppressive... |
|
|
Invention
|
Method and composition for crispr-cas gene editing system. The present invention relates to a met... |
|
|
Invention
|
Antibody targeting b7-h3 and use thereof. The present invention provides an antibody targeting B7... |
|
|
Invention
|
Chimeric antigen receptor targeting ccr8 and use thereof. A chimeric antigen receptor targeting C... |
|
|
Invention
|
Engineered immune cell with cd7 gene knock-out and use thereof. Disclosed herein are an engineere... |
|
|
Invention
|
Engineered immune cell with ciita gene knock-out and use thereof. Disclosed herein are an enginee... |
|
2022
|
Invention
|
Engineered immune cell and use thereof. Provided is an engineered immune cell, which expresses ce... |
|
|
Invention
|
Engineered immune cell and use thereof. An engineered immune cell expressing a cell surface molec... |
|
|
Invention
|
Engineered immune cell and use thereof. The present invention relates to an engineered immune cel... |
|
|
Invention
|
Engineered immune cell and use thereof. Provided are an engineered immune cell and a use thereof ... |
|
|
Invention
|
Method and composition for cellular immunotherapy. The present invention provides a method and a ... |
|
|
Invention
|
Nanobody targeting claudin18.2 and use thereof. The present invention provides a nanobody targeti... |
|
|
Invention
|
Engineered immune cell and use thereof. Provided are an engineered immune cell, which expresses: ... |
|
|
Invention
|
Gprc5d-targeting antibody and use thereof. The present invention provides a GPRC5D-targeting anti... |
|
|
Invention
|
Ror1-targeting antibody and use thereof. The present invention provides an ROR1-targeting antibod... |
|
2021
|
Invention
|
Novel chimeric antigen receptor and use thereof. Provided is a chimeric antigen receptor, compris... |
|
|
Invention
|
Cd19-targeting humanized antibody and use thereof. The present invention provides a CD19-targetin... |
|
|
Invention
|
Antibody targeting claudin18.2 and use thereof. Provided in the present invention are an antibody... |
|
|
Invention
|
Nkg2a-targeting antibody and use thereof. Provided are an NKG2A-targeting antibody, and a multisp... |
|
|
Invention
|
Lir1-targeted antibody and use thereof. The present invention provides an LIR1-targeted antibody,... |
|
|
Invention
|
Cd7-targeting humanized antibody and use thereof. The present invention provides a CD7-targeting ... |
|
|
Invention
|
Chimeric antigen receptor targeting cd7 and use thereof. Provided is an engineered immune cell. T... |
|
|
Invention
|
Bcma-targeting single-domain antibody and use thereof. Provided in the present invention are a BC... |
|
|
Invention
|
Chimeric antigen receptor comprising novel co-stimulatory domain and use thereof. Provided is a c... |
|
|
G/S
|
Pharmaceutical preparations; Vaccines; Drugs for medical purposes; Biological preparations for me... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer, autoimmune diseases, viral and bacterial... |
|
|
Invention
|
Chimeric antigen receptor targeting nk activated receptor. The present invention relates to a nov... |
|
|
Invention
|
Novel co-stimulatory domain and uses thereof. A chimeric antigen receptor, containing a ligand bi... |
|
|
Invention
|
Engineered immune cell and use thereof. Provided is an engineered immune cell. The engineered imm... |
|
|
Invention
|
Engineered immune cell for allotransplantation. Provided is an engineered immune cell. The expres... |
|
|
Invention
|
Engineered immune cell expressing nk inhibitory molecule and use thereof. Provided is an NK inhib... |
|
|
Invention
|
Engineered immune cell and use thereof. An engineered immune cell, which expresses (i) a cell sur... |
|
|
Invention
|
Novel chimeric antigen receptor and use thereof. The present invention provides a novel chimeric ... |
|
|
Invention
|
Immune cell comprising chimeric antigen receptor and use thereof. Provided is an engineered immun... |
|
|
Invention
|
Multi-chain chimeric antigen receptor and use thereof. Provided in the present invention is a mul... |
|
2020
|
Invention
|
T cell receptor fusion protein and use thereof. The present invention provides a recombinant T ce... |
|
|
Invention
|
Gene editing method based on adenovirus. Provided is a recombinant adenovirus, which comprises a ... |
|
|
Invention
|
Modified t cells and uses thereof.
The present invention relates to modified T cells with reduce... |
|
|
Invention
|
Engineered chimeric guide rna and uses thereof. The present invention relates to engineered chime... |
|
2018
|
Invention
|
Modified t cells and uses thereof. Provided are modified T cells with reduced or abolished TCR/CD... |
|
|
Invention
|
Engineered chimeric guide rna and uses thereof. Provided are engineered chimeric guide RNAs and t... |
